Skip to main content
OpenTrials
Completed

NCT Number: NCT02996747

Low Grade Chondrosarcoma Versus Enchondroma

The purpose of this project is to verify possible clinical and radiological findings with regard to distinguishing enchondroma from low grade chondrosarcoma of the long bones. In addition, this study presents the outcome of patients with enchondroma and low grade chondrosarcoma of the long bones who were treated with curettage (intralesional surgery).

Completed

Looking for future studies?

Notify Me

Key information

About this study

The investigators retrospectively review the records of 65 patients with enchondroma and 37 patients with low grade chondrosarcoma of the limbs treated by curettage between 1988 and 2014 in a single Institution.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • chondroma or low grade chondrosarcoma of long bones

Exclusion criteria

  • chondroma or low grade chondrosarcoma of spine and pelvis

Treatment and study plan

curettage (intralesional surgery)

Procedure

comparison of two different tumors treated by curettage

Primary outcomes

  1. Local recurrence rate of patients with chondroma or low grade chondrosarcoma treated by curettage (intralesional surgery)

    Time frame: 36 months

Sponsors and collaborators

Lead sponsor

Istituto Ortopedico Rizzoli

Other

Registry information

Official study title

Low Grade Chondrosarcoma Versus Enchondroma: Challenges in Diagnosis and Management

Acronym: CONDRO1

Important dates

Study start
2016
Primary completion
2016
Study completion
2016
First posted
Dec 19, 2016
Registry last updated
Dec 22, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.